Contains information about title and source of a journal
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.
Cancer prevention research [1940-6207] Gillen, Daniel yr:2015 vol:8 iss:3 pg:222 -230
Contains list of services for current record
Highwire Press American Association for Cancer Research
Highwire Press Free
Availability of free/open access journals is not guaranteed
This journal in
ISI's Journal Citation Report (JCR) Science Edition 2014 Release
Note:Check the Impact Factors for this journal.
Get information about this journal in
Ulrich's Periodical Directory
Note:Find out if this journal is peer-reviewed/refereed, who publishes or edits it, and more
Ask a Librarian
Note:Send us your questions, problems and/or comments.
You may also call us at (646) 962-2570, Monday through Friday (9AM-6PM).
Current access problems
Note:Read about current access problems which may affect you.
Have a question?
Visit our Freqently Asked Questions page
© 2017 SFX by Ex Libris Inc.